Skip to main content

Advertisement

Log in

No prognostic impact of isolated lymphovascular invasion after radical resection of rectal cancer—results of a multicenter observational study

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background

The prognostic impact of isolated lymphovascular invasion (LVI) after radical resection of rectal cancer is controversially discussed. However, it could be relevant to decide for an adjuvant treatment.

Aim

The aim of the analysis was, based on the data of an observational study, to determine the prognostic relevance of the isolated LVI.

Materials and methods

Patients after radical resection of rectal cancer with no hemangioinvasion were subdivided in three groups: I—no LVI, no lymph node metastases (LNM); II—positive LVI, no LNM; III—positive LNM. Five-year local recurrence rate, distant metastases-free and disease-free survival were determined uni- and multivariate.

Results

Patients, n = 846, were studied (I, n = 471; II, n = 75; III, n = 300). The univariate comparison between the groups revealed the following 5-year results: local recurrence rate: 9.4 vs 10.0 vs 14.0%; distant metastases-free survival: 84.1 vs 82.5 vs 49.3%; disease-free survival: 83.2 vs 80.7 vs 45.5%. The differences between groups I and III were significant, but not between groups I and II. The determined higher disease-free survival rate in group II vs group III was significant (P = 0.041), but the differences in local recurrence rate and rate of distant metastases did not reach statistical significance. The multivariate analysis revealed no impact of the isolated LVI on the oncological outcome.

Conclusion

The isolated LVI has no independent prognostic impact on the local recurrence rate and long-term survival after radical resection of rectal cancer. Based on this finding, no indication for an adjuvant treatment in these patients can be derived.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Soreide O; on behalf of the Norwegian Rectal Cancer Group (2004) Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum 47:48–58

    Article  PubMed  Google Scholar 

  2. Cecil TD, Sexton R, Moran BJ, Heald RJ (2004) Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 45:1145–1150

    Google Scholar 

  3. Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479–1482

    Article  PubMed  CAS  Google Scholar 

  4. Park YJ, Park KJ, Park J, Lee KU, Choe KJ, Kim J (1999) Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated patients. World J Surg 23:721–726

    Article  PubMed  CAS  Google Scholar 

  5. Greene FL, Stewart AK, Norton HJ (2004) New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis. J Clin Oncol 22:1778–1784

    Article  PubMed  Google Scholar 

  6. Wang HS, Liang WY, Lin TC, Chen WS, Jiang JK, Yang SH, Chang SC, Lin JK (2005) Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis Colon Rectum 48:1182–1192

    Article  PubMed  Google Scholar 

  7. Meyer W, Awad-Allah A, Steinhäuser BB, Jurowich C, Kaiser A, Gebhardt C (2001) Prognostic importance of isolated peritumoral lymphangiosis carcinomatosa in lymph-node-negative colorectal carcinoma. Langenbecks Arch Surg 386:124–131

    Article  PubMed  CAS  Google Scholar 

  8. Meguerditchian AN, Bairati I, Lagace R, Harel F, Kibrite A (2005) Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma. Am J Surg 189:707–713

    Article  PubMed  Google Scholar 

  9. Heide J, Krull A, Berger J (2004) Extracapsular spread of nodal metastasis as a prognostic factor in rectal cancer. Int J Radiat Oncol Biol Phys 58:773–778

    Article  PubMed  Google Scholar 

  10. Law WL, Chu KW (2002) Local recurrence following total mesorectal excision with double-stapling anastomosis for rectal cancers: analysis of risk factors. World J Surg 26:1272–1276

    Article  PubMed  Google Scholar 

  11. Law WL, Ho JWC, Chan R, Au G, Chu KW (2005) Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy. Dis Colon Rectum 48:218–226

    Article  PubMed  Google Scholar 

  12. Tang R, Wang JY, Tsao KC, Ho YS (1999) Lymphangiosis as a predictor of outcome in patients with primary diffusely infiltrative adenocarcinoma of the colon and rectum. Arch Surg 134:157–160

    Article  PubMed  CAS  Google Scholar 

  13. Celen O, Yildirim E, Berberoglu U (2004) Factors influencing outcome of surgery for stage I rectal cancer. Neoplasm 51:487–490

    CAS  Google Scholar 

  14. Marusch F, Koch A, Schmidt U, Meyer L, Steinert R, Pross M, Köckerling F, Bauer H, Schönleben K, Halbfass HJ, Scheele J, Gastinger I, Lippert H; Studiengruppe “Kolon/Rektum Karzinome (Primärtumor)” (2003) Importance of rectal extirpation for the therapy concept of low rectal cancers. Chirurg 74:341–352

    Article  PubMed  CAS  Google Scholar 

  15. Marusch F, Koch A, Schmidt U, Zippel R, Geissler S, Pross M, Roessner A, Köckerling I, Lippert H (2002) “Colon-/rectal carcinoma” prospective studies as comprehensive surgical quality assurance. Chirurg 73:138–146

    Article  PubMed  CAS  Google Scholar 

  16. Deinlein P, Reulbach U, Stolte M, Vieth M (2003) Risk factors for lymphatic metastasis from pT1 colorectal adenocarcinoma. Pathologe 24:387–393

    Article  PubMed  CAS  Google Scholar 

  17. Law WL, Chu KW (2004) Anterior resection for rectal cancer with mesorectal excision. A prospective evaluation of 622 patients. Ann Surg 240:260–268

    Article  PubMed  Google Scholar 

  18. Rosenberg R, Friederichs J, Gertler R, Hoos A, Mueller J, Nahrig J, Nekarda H, Siewert JR (2004) Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer. Int J Colorectal Dis 19:430–437

    Article  PubMed  Google Scholar 

  19. Isaka N, Nozue M, Doy M, Fukao K (1999) Prognostic significance of perirectal lymph node micrometastasis in Dukes’ B rectal carcinoma: an immunohistochemical study by CAM5.2. Clin Cancer Res 5:2065–2068

    PubMed  CAS  Google Scholar 

  20. Charbit L, Peschaud F, Penna C (2005) Lymph nodes in rectal cancer. J Chir (Paris) 142:85–92

    CAS  Google Scholar 

  21. Wang C, Zhou ZG, Wang Z, Chen DY, Zheng YC, Zhao PG (2005) Nodal spread and micrometastasis within the mesorectum. World J Gastroenterol 11:3586–3590

    PubMed  Google Scholar 

  22. Hassan C, Zullo A, Risio M, Rossini FP, Morini S (2005) Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis. Dis Colon Rectum 48:1588–1596

    Article  PubMed  Google Scholar 

  23. Okabe S, Shia J, Nash G, Wong WD, Guillem JG, Weiser MR, Temple L, Sugihara K, Paty PB (2004) Lymph node metastasis in T1 adenocarcinoma of the colon and rectum. J Gastrointest Surg 8:1032–1039

    Article  PubMed  Google Scholar 

  24. Mouta Carriera C, Nasser SM, di Tomaso E, Padera TP, Boucher Y, Tomarev SI, Jain RK (2001) LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res 61:8079–8084

    Google Scholar 

  25. Jackson DG (2003) The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1. Trends Cardiovasc Med 13:1–7

    Article  PubMed  CAS  Google Scholar 

  26. Sleeman JP, Krishnan J, Kirkin V, Baumann P (2001) Markers for the lymphatic endothelium: in search of the holy grail? Microsc Res Tech 55:61–69

    Article  PubMed  CAS  Google Scholar 

  27. Rodriguez-Niedenfuhr M, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Tomarev SI, Wilting J (2001) Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts. Anat Embryol 204:399–406

    Article  PubMed  CAS  Google Scholar 

  28. Wilting J, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Borges J, Stark GB, Alitalo K, Tomarev SI, Niemeyer C, Rossler J (2002) The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J 16:1271–1273

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Henry Ptok.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ptok, H., Meyer, F., Steinert, R. et al. No prognostic impact of isolated lymphovascular invasion after radical resection of rectal cancer—results of a multicenter observational study. Int J Colorectal Dis 22, 749–756 (2007). https://doi.org/10.1007/s00384-006-0220-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-006-0220-8

Keywords

Navigation